Kura Oncology
KURA • NASDAQ
Kura Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Troy Edward Wilson, with a market cap of $781.7M.
Market Cap$781.7M
Employees142.0
CEOTroy Edward Wilson
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
KUR
Kura Oncology FAQ
Common questions about Kura Oncology
Kura Oncology is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $21.5M.
Kura Oncology has approximately 142 employees.